Aquinafil

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AQUINAFIL™ Quinapril hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Aquinafil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your […]

Read more

Depo-Nisolone

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DEPO-NISOLONE® methylprednisolone acetate Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before being treated with DEPO-NISOLONE suspension for injection.This leaflet answers some common questions about DEPO-NISOLONE.It does not contain all the available information.It does not take the place of talking to your […]

Read more

Tezmota

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TEZMOTA® pegfilgrastim (rbe) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Tezmota. It does not contain all the available information. It does not take the place of talking to your doctor, nurse or pharmacist. All medicines have risks and benefits. […]

Read more

Codapane Forte 500/30mg

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CODAPANE FORTE Consumer Medicine Information (CMI) summary The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. WARNING: Important safety information is provided in a boxed warning in the full CMI. Read before […]

Read more

Paxtine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PAXTINE paroxetine (hydrochloride anhydrate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PAXTINE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]

Read more

Anpec (new formulation)

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ANPEC (New formulation) verapamil hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Anpec. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and […]

Read more

Lioresal Intrathecal

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LIORESAL® INTRATHECAL baclofen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Lioresal Intrathecal. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was […]

Read more

Efexor

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EFEXOR®-XR Venlafaxine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Efexor-XR. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your […]

Read more

Lamivudine Alphapharm

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LAMIVUDINE ALPHAPHARM contains the active ingredient lamivudine CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you start LAMIVUDINE ALPHAPHARM tablets. This leaflet answers some common questions about LAMIVUDINE ALPHAPHARM tablets. It does not contain all the available information. It does not […]

Read more

Polivy

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. POLIVY® 191021 This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . polatuzumab vedotin Consumer Medicine Information What is in […]

Read more
1 2 3 4 5 14